Characterization of protein unable to bind von Willebrand factor in recombinant factor VIII products-Reference-Cited by-同舟云学术

Characterization of protein unable to bind von Willebrand factor in recombinant factor VIII products

Published:2021-02-24 Issue:4 Volume:19 Page:954-966
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J. Thromb. Haemost.

Author:

Chun Haarin¹^ORCID,Pettersson John R.¹^ORCID,Shestopal Svetlana A.¹,Wu Wells W.¹^ORCID,Marakasova Ekaterina S.¹^ORCID,Olivares Philip¹^ORCID,Surov Stepan S.¹,Ovanesov Mikhail V.¹^ORCID,Shen Rong‐Fong¹^ORCID,Sarafanov Andrey G.¹^ORCID

Affiliation:

1. Center for Biologics Evaluation and Research U. S. Food and Drug Administration Silver Spring MD USA

Funder

Center for Tobacco Products

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15257

Reference48 articles.

1. Defining 'full-length' recombinant factor VIII: a comparative structural analysis

2. Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance

3. Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A

4. The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor

5. Factor VIII and von Willebrand factor are ligands for the carbohydrate-receptor Siglec-5

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shifting Paradigms and Arising Concerns in Severe Hemophilia A Treatment;Seminars in Thrombosis and Hemostasis;2024-01-15

2. Plasma Clearance of Coagulation Factor VIII and Extension of Its Half-Life for the Therapy of Hemophilia A: A Critical Review of the Current State of Research and Practice;International Journal of Molecular Sciences;2023-05-11

3. Modified expi293 cell culture system using piggyBac transposon enables efficient production of human FVIII;International Journal of Hematology;2022-10-14

4. Characterization of interaction between blood coagulation factor VIII and LRP1 suggests dynamic binding by alternating complex contacts;Journal of Thrombosis and Haemostasis;2022-10